Pharmacokinetics of a commercially available product and a compounded formulation of extended-release levetiracetam after oral administration of a single dose in cats.

Objective: To compare pharmacokinetics of levetiracetam in serum and CSF of cats after oral administration of extended-release (ER) levetiracetam.

Animals: 9 healthy cats.

Procedures: Cats received 1 dose of a commercially available ER levetiracetam product (500 mg, PO).